Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 85,713 | 25,062 | 20,085 | 11,576 | 27,537 |
| Cost of Goods | N/A | 691 | 749 | 715 | 457 |
| Gross Profit | 85,713 | 24,371 | 19,336 | 10,861 | 27,080 |
| Operating Expenses | 72,598 | 65,387 | 48,229 | 43,348 | 27,941 |
| Operating Income | 13,115 | -40,325 | -28,144 | -31,772 | -404 |
| Interest Expense | 153 | 217 | 251 | 138 | 83 |
| Other Income | 1,463 | 1,050 | 2,734 | 3,837 | 2,584 |
| Pre-tax Income | 14,425 | -39,492 | -25,661 | -28,073 | 2,097 |
| Income Tax | 3,526 | -88 | N/A | N/A | N/A |
| Net Income Continuous | 10,899 | -39,404 | -25,661 | -28,073 | 2,097 |
| Net Income | $10,899 | $-39,404 | $-25,661 | $-28,073 | $2,097 |
| EPS Basic Total Ops | 597.72 | -2,422.35 | -1,635.87 | -2,233.60 | -141.57 |
| EPS Basic Continuous Ops | 600.62 | -2,417.72 | -1,636.54 | -2,239.11 | 242.61 |
| EPS Diluted Total Ops | 566.26 | -2,422.35 | -1,635.87 | -2,233.60 | -141.57 |
| EPS Diluted Continuous Ops | 568.61 | -2,417.72 | -1,636.54 | -2,239.11 | 242.61 |
| EBITDA(a) | $15,528 | $-38,490 | $-26,344 | $-30,865 | $417 |